The global neurorehabilitation devices market size was valued at over USD 2 billion in 2024 and estimated to register a significant CAGR of around 14% during the forecast period from 2025 to 2030. The increasing prevalence of numerous neurological disorders across the globe is a primary factor to drive the market growth. Furthermore, the technological advancement in healthcare and the growing aging population around the world is further anticipated to boost the market growth over the forecast period. it is estimated that around 1%-2% of the world’s population over the age of 60 is estimated to suffer from Parkinson’s disease.
Market Snapshot:
| Benchmark Year | 2022 | ||
| Market Size | > USD 2 Billion in 2024 | ||
| Market Growth (CAGR) | ~ 14% (2025-2030) | ||
| Largest Market Share | North America | ||
| Analysis Period | 2020-2030 | ||
| Market Players | Bionik Laboratories Corp., Medtronic plc, Hocoma AG, Ekso Bionics, and Neurostyle Pte Ltd. |
Emerging Trends Fueling the Neurorehabilitation Devices Market Growth:
The global neurorehabilitation devices market is witnessing strong growth driven by technological advancements in robotics, virtual reality (VR), and brain-computer interface (BCI) technologies. A major trend is the increasing adoption of robot-assisted therapy systems for improving motor recovery in patients with neurological disorders such as stroke, spinal cord injury, and Parkinson’s disease. These systems offer precise, repetitive, and intensive training that enhances neuroplasticity and accelerates rehabilitation outcomes. Additionally, virtual reality and gamification-based rehabilitation tools are gaining traction for their ability to engage patients in immersive, interactive environments that boost motivation and adherence to therapy. The integration of AI and machine learning is further enhancing data-driven therapy customization and patient progress tracking.
Another emerging trend is the shift toward home-based and tele-rehabilitation solutions, accelerated by advancements in wearable technologies and remote monitoring systems. This trend was notably reinforced during the COVID-19 pandemic and continues to grow as healthcare systems embrace digital transformation. The miniaturization of devices and the use of cloud-based platforms for real-time data sharing are enabling patients to receive continuous therapy outside clinical settings. Furthermore, growing awareness of neurorehabilitation benefits, rising healthcare expenditure, and the increasing prevalence of neurological disorders globally are propelling market growth. As a result, manufacturers are focusing on developing affordable, portable, and user-friendly rehabilitation devices that support personalized therapy and improve patient independence.
Neurorehabilitation Devices Market Key Drivers:
- Rising Incidence of Neurological Disorders: The increasing prevalence of neurological disorders, such as stroke, traumatic brain injury, spinal cord injury, Parkinson’s disease, and multiple sclerosis, is a significant driving factor for the neurorehabilitation devices market. These devices play a crucial role in assisting and facilitating the rehabilitation process for individuals with neurological conditions, improving their functional abilities and quality of life.
- Advancements in Technology: Technological advancements have significantly impacted the development of neurorehabilitation devices. Innovations such as robotics, virtual reality, brain-computer interfaces, and neurostimulation techniques have expanded the capabilities and effectiveness of these devices. The integration of advanced technologies into neurorehabilitation devices has led to more personalized, interactive, and efficient rehabilitation interventions.
- Growing Aging Population: The global aging population is increasing, leading to a higher prevalence of age-related neurological conditions and disabilities. Neurorehabilitation devices are vital in addressing the specific needs of elderly individuals and promoting their functional recovery. These devices assist in mobility, motor function improvement, cognitive rehabilitation, and daily living activities for the aging population.
- Rehabilitation Paradigm Shift: The field of neurorehabilitation has witnessed a paradigm shift from traditional therapy approaches to more evidence-based, task-specific, and technology-driven interventions. Neurorehabilitation devices provide therapists with tools to deliver more precise and targeted rehabilitation, enhancing patient outcomes and accelerating recovery. This shift in rehabilitation approaches has contributed to the demand for neurorehabilitation devices.
- Favorable Reimbursement Policies: The availability of favorable reimbursement policies and support from healthcare systems and insurance providers has a significant impact on the adoption of neurorehabilitation devices. Reimbursement for these devices and associated therapy services reduces the financial burden on patients and encourages healthcare facilities to invest in advanced rehabilitation technologies, driving market growth.
- Awareness and Demand for Personalized Rehabilitation: Increased awareness among patients, caregivers, and healthcare professionals about the benefits of personalized rehabilitation programs has fueled the demand for neurorehabilitation devices. These devices can be customized to meet individual patient needs and provide tailored rehabilitation interventions, leading to better patient engagement, compliance, and outcomes.
- Collaborative Efforts and Research Initiatives: Collaborative efforts between academia, research institutions, and industry players have led to significant advancements in neurorehabilitation device development. Research initiatives focusing on understanding neuroplasticity, neurorecovery mechanisms, and rehabilitation strategies have paved the way for innovative device solutions. Collaborations and investments in research and development activities continue to drive the growth of the neurorehabilitation devices market.
- Improved Access to Rehabilitation Services: Efforts to improve access to rehabilitation services, particularly in developing regions, have increased the demand for neurorehabilitation devices. These devices help address the shortage of rehabilitation professionals by providing automated and portable solutions that can be used in community healthcare settings. Improved access to rehabilitation services and devices has a positive impact on patient outcomes and market expansion.
Future Opportunities Reshaping the Neurorehabilitation Devices Market’s Evolution:
The neurorehabilitation devices market presents significant opportunities driven by the rising global burden of neurological disorders and the growing need for advanced rehabilitation solutions. With the increasing prevalence of conditions such as stroke, traumatic brain injuries, and multiple sclerosis, healthcare providers are actively seeking innovative technologies that can enhance patient recovery and reduce long-term disability. This creates immense potential for companies developing robotic exoskeletons, neurostimulation devices, and virtual reality-based rehabilitation systems. Furthermore, expanding healthcare infrastructure in emerging economies—especially in Asia-Pacific and Latin America—offers new avenues for market penetration, as governments and private institutions invest in modern rehabilitation centers and assistive technologies.
Another major opportunity lies in the integration of digital health and artificial intelligence (AI) with neurorehabilitation devices. AI-driven analytics can personalize therapy sessions by analyzing patient data and optimizing treatment protocols, leading to better recovery outcomes. Additionally, the growing acceptance of home-based and remote rehabilitation platforms opens new revenue streams, especially as patients and caregivers prefer convenient, cost-effective solutions. Collaborations between medical device manufacturers, research institutions, and healthcare providers are expected to accelerate innovation in sensor-based wearables, brain-computer interfaces (BCIs), and tele-rehabilitation systems. As healthcare systems worldwide prioritize neurorehabilitation to improve quality of life and reduce healthcare costs, the market is poised for robust expansion supported by technological progress and increasing adoption in both clinical and home care settings.
Market Insights:
The global neurorehabilitation devices market is bifurcated into product, application, end-user, and geography. On the basis of product, the market is further segmented into neurorobotic systems, brain-computer interfaces, wearable devices, and non-invasive stimulators. The neurorobotic systems segment is accounted to hold the largest revenue share of around one-third percent of the market by the end of the analysis period. Technological advancement and the increasing incidence of neurological disorders are some of the major factors driving the market growth. furthermore, the growth in the geriatric population is further expected to fuel the segment growth over the forecast period.
The neurorehabilitation devices comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.
Neurorehabilitation Devices Market Segmentation:
By Product:
- Neurorobotic Systems
- Brain Computer Interface
- Wearable Devices
- Non-Invasive Stimulators
By Application:
- Stroke
- Parkinson`s Disease
- Brain & Spinal Cord Injury
- Cerebral Palsy
- Multiple Sclerosis
- Others
By End-User:
- Rehabilitation Centers
- Hospitals & Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Geographic Coverage: North America Dominated the Global Neurorehabilitation Devices Market
Geographically, North America dominated the global neurorehabilitation devices market in 2024 and is expected to grow at similar trends over the forecast period. The strong investment in research and development activities and the presence of well-structured healthcare infrastructure are some major factors to drive the market growth in the region. Furthermore, the rising prevalence of neurological disorders and the increasing investment by major players are further expected to fuel the market growth in North America. Moreover, the technological advancement, increasing adoption of neurorehabilitation devices by hospitals, and growing demand for safe products are expected to propel the market growth in the region.
Competitive Assessment
Some of the major market players operating in the global neurorehabilitation devices market are Bionik Laboratories Corp., Medtronic plc, Hocoma AG, Ekso Bionics, and Neurostyle Pte Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies:
- Bionik Laboratories Corp.
- Medtronic plc
- Hocoma AG
- Ekso Bionics
- Neurostyle Pte Ltd.
- Neuro Device Group S.A.
- Saebo, Inc.
- Tyromotion GmbH
- ReWalk Robotics
- Boston Scientific Corporation
Key Questions Answered by Neurorehabilitation Devices Market Report
- Global neurorehabilitation devices market forecasts from 2025-2030
- Regional neurorehabilitation devices market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
- Country-level forecasts from 2025-2030 covering 15 major countries from the regions as mentioned above
- Neurorehabilitation devices submarket forecasts from 2025-2030 covering the market by product, by application, by end-user, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis about market
- Analysis of the key factors driving and restraining the growth of the global, regional, and country-level markets from 2025-2030
- Competitive Landscape and market positioning of top 10 players operating in the market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Neurorehabilitation Devices Market Portraiture
2.2. Global Neurorehabilitation Devices Market, by Product, 2020 (USD Mn)
2.3. Global Neurorehabilitation Devices Market, by Application, 2020 (USD Mn)
2.4. Global Neurorehabilitation Devices Market, by End-User, 2020 (USD Mn)
2.5. Global Neurorehabilitation Devices Market, by Geography, 2020 (USD Mn)
3. Global Neurorehabilitation Devices Market Analysis
3.1. Neurorehabilitation Devices Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis
4. Global Neurorehabilitation Devices Market By Product, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Neurorobotic Systems
4.3. Brain Computer Interface
4.4. Wearable Devices
4.5. Non-Invasive Stimulators
5. Global Neurorehabilitation Devices Market By Application, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Stroke
5.3. Parkinson`s Disease
5.4. Brain & Spinal Cord Injury
5.5. Cerebral Palsy
5.6. Multiple Sclerosis
5.7. Others
6. Global Neurorehabilitation Devices Market By End-User, 2018 – 2027 (USD Mn)
6.1. Overview
6.2. Rehabilitation Centers
6.3. Hospitals & Clinics
6.4. Others
7. North America Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)
7.1.1. Overview
7.1.2. North America Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
7.1.3. North America Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
7.1.4. North America Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
7.1.5. North America Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
7.1.5.1.2. U.S. Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
7.1.5.1.3. U.S. Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
7.1.5.2.2. Canada Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
7.1.5.2.3. Canada Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8. Europe Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)
8.1.1. Overview
8.1.2. Europe Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.3. Europe Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.4. Europe Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5. Europe Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.1.2. Germany Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.1.3. Germany Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.2.2. U.K. Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.2.3. U.K. Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.3.2. France Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.3.3. France Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.4.2. Italy Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.4.3. Italy Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
9. Asia Pacific Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)
9.1.1. Overview
9.1.2. Asia Pacific Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.3. Asia Pacific Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.4. Asia Pacific Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
9.1.5. Asia Pacific Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.5.1.2. China Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.5.1.3. China Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.5.2.2. Japan Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.5.2.3. Japan Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
10. Latin America (LATAM) Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)
10.1.1. Overview
10.1.2. Latin America Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.3. Latin America Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.4. Latin America Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
10.1.5. Latin America Neurorehabilitation Devices Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.5.1.2. Brazil Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.5.1.3. Brazil Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.5.2.2. Mexico Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.5.2.3. Mexico Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
11. Middle East and Africa Neurorehabilitation Devices Market Analysis and Forecast, 2018 – 2027 (USD Mn)
11.1.1. Overview
11.1.2. MEA Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.3. MEA Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.4. MEA Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
11.1.5. Middle East and Africa Neurorehabilitation Devices Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.5.1.2. GCC Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.5.1.3. GCC Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
11.1.5.2. South Africa
11.1.5.2.1. South Africa Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.5.2.2. South Africa Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.5.2.3. South Africa Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
11.1.5.3. Rest of MEA
11.1.5.3.1. Rest of MEA Neurorehabilitation Devices Market by Product (2018-2027 USD Mn)
11.1.5.3.2. Rest of MEA Neurorehabilitation Devices Market by Application (2018-2027 USD Mn)
11.1.5.3.3. Rest of MEA Neurorehabilitation Devices Market by End-User (2018-2027 USD Mn)
12. Company Profiles
12.1. Bionik Laboratories Corp.
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Medtronic plc
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. Hocoma AG
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. Ekso Bionics
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. Neurostyle Pte Ltd.
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. Neuro Device Group S.A.
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. Saebo, Inc.
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Tyromotion GmbH
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. ReWalk Robotics
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. Boston Scientific Corporation
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis
$ 5200/- Multi User License
We understand that every business has unique requirements. This report can be customized based on:
- Deep regional & country-level market intelligence
- Application-specific and end-use industry segmentation
- Competitive landscape & strategic benchmarking
- Go-to-market and expansion strategy insights
- Custom data cuts aligned to your business goals
- Structured Primary Research Framework
- On-Demand Industry Expert Interviews Available
- Dedicated Analyst Support
- Custom Data On Request
- Post-Purchase Strategy Consultation
- Complimentary 30-min Analyst Session
- 30% of Our Clients Are Returning Enterprise Buyers